Analysis of the Variety of Sequence Variants of Cleft Lip and/or Palate Candidate Gene SOS1
Ingrida Uktverytė, Laima Ambrozaitytė, Albertas Timinskas, Aušra Matulevičienė, Algirdas Utkus, Vaidutis Kučinskas
Background. Orofacial clefting (OFC) is developmental defect in the upper lip resulting from failure of the medial nasal process and/or incomplete fusion of the palatal shelves on either side. It is one of the most common birth defects. Incidence of OFC varies from 1/500 to 1/1000 births. In the population of Lithuania the incidence of OFC is 1/544 and this statistics is akin to Caucasian (European) populations statistics. The goal of this study was to find SOS1 gene’s sequence varii ants which may contribute to nonsyn- dromic cleft lip and/or palate (NS-CL/P) phenotype in Lithuanian population. 23 exons of SOS1 gene were analysed by direct sequencing because it gives opportunity to find variants not only in coding but also in flanking sequences as NS-CL/P risk factors most probably are non patogenic mutations which usually cause complex phenotypes.
Material and methods. All 23 exons of SOS1 gene were sequenced for 30 patients with NS-CL/P and 60 controls.
Results. 19 different variants were identified, 15 of which are SNPs and four in/del polymorphisms. Allele and genotype frequencies are similar to other European populations (HapMap Project). j2 test was performed to find statistically significant variants. One variant c.1075-98_1075-97 insGTG (rs56299761) near exon 9 shows statistical significance (j2=4.841; p=0.028), another variant c.2792-51_2792-50 insA near exon 18 was close to significance (j2=3.388; p=0.066).
Conclusion. Results of this study show SOS1 gene’s assocciation with NS-CL/P. SOS1 gene can be considered as candidate gene for NS-CL/P in the population of Lithuania according to this work results and known interaction with other candidate genes FGFR1, ERBB2, EGFR confirms its importance to NS-CL/P phenotype.
Keywords: nonsyndromic cleft lip and/or palate, SOS1 gene, sequence variants, candidate gene, %2 test.